Aside from the demonstration of MMR protein deficiency that favors UEC, there are currently no reliable immunohistochemical markers that can be used to differentiate between SMARCA4‐deficient (and MMR protein‐intact) UEC from SMARCA4‐deficient uterine sarcoma. The gene discussed is SMARCA4; the disease is uterine corpus sarcoma.